Oblique Versus Transverse Orientation Approach for Internal Jugular Venous Cannulation in Pediatrics

NCT05656937 | Completed

• 1 other identifier: IndonesiaUAnes109
• Study Type: interventional
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

this study aimed to compare oblique versus transverse orientation approach in jugular venous cannulation in term of cannulation success in pediatric heart surgery patients

Conditions

Heart; Surgery, Heart, Functional Disturbance as Result; Pediatric ALL

Keywords

oblique orientation; transverse orientation; internal jugular venous cannulation; ultrasound guided; short axis; oblique axis

Outcome Measures

Primary Outcomes (1)

• % of patients with successful cannulation in first attempt

  The number of patients undergo cannulation with first attempt success are shown in percentage

  at the procedure of cannulation

Secondary Outcomes (1)

• % of patients with successful cannulation with designed approach

  at the procedure of cannulation

Study Arms (2)

Oblique orientation

EXPERIMENTAL

cannulation will be oblique approach

Procedure: internal jugular venous cannulation

transverse approach

ACTIVE COMPARATOR

cannulation will be transverse approach

Procedure: internal jugular venous cannulation

Interventions

internal jugular venous cannulation PROCEDURE

internal jugular venous cannulation

Oblique orientation; transverse approach

Eligibility Criteria

• Age: 3 Years - 12 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17)

You may qualify if:

• patients age 3 months to 12 years old, weight 5-20 kg, male or female
• who undergo heart surgery and indicated to have central venous cannulation
• American Society of Anesthesiologist Physical Class 1-3
• Family or representation of the patients agreed to participate in this study and sign informed consent

You may not qualify if:

• history of surgery in the area of cannulation
• already placed central venous cannulation \<72 hours in the same venous
• sign of infection, hematoma, emphysema, in the area of cannulation
• history of cervical trauma
• severe hemostatic disorder (International Normalized Ratio\>2, thrombocyte \<50.000, Prothrombin time\>1.5 times, Activated Partial Thromboplastin Time \> 1.5 times

Sponsors & Collaborators

• Indonesia University: lead

Study Sites (1)

Cipto Mangunkusumo Central National Hospital

Jakarta, 10430, Indonesia

Location

MeSH Terms

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Condition Hierarchy (Ancestors)

Leukemia, Lymphoid; Leukemia; Neoplasms by Histologic Type; Neoplasms; Hematologic Diseases; Hemic and Lymphatic Diseases; Lymphoproliferative Disorders; Lymphatic Diseases; Immunoproliferative Disorders; Immune System Diseases

Study Officials

• aldy heriwardito, Doctor

  Indonesia University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, INVESTIGATOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: July 18, 2021
• First Posted: December 19, 2022
• Study Start: February 1, 2021
• Primary Completion: May 31, 2021
• Study Completion: May 31, 2021
• Last Updated: December 19, 2022

Record last verified: 2022-12

Locations

ID (1)